Kanae Kawai, Shinji Matsumoto, Akikazu Harada, Ryota Sada, Takeshi Harada, Yuuya Kasahara et al. Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug. // In Vitro Cellular & Developmental Biology - Animal. – 2026. – DOI: 10.1007/s11626-026-01154-2. – URL: https://doi.org/10.1007/s11626-026-01154-2
Kanae Kawai, Shinji Matsumoto, Akikazu Harada, Ryota Sada, Takeshi Harada, Yuuya Kasahara, Satoshi Obika, Yasushi Okamura, & Akira Kikuchi (2026). Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug. In Vitro Cellular & Developmental Biology - Animal. https://doi.org/10.1007/s11626-026-01154-2
Kanae Kawai, et al. “Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug.” In Vitro Cellular & Developmental Biology - Animal, 2026. doi:10.1007/s11626-026-01154-2.
@article{Kawai2026,
title = {Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug},
author = {Kawai, Kanae and Matsumoto, Shinji and Harada, Akikazu and Sada, Ryota and Harada, Takeshi and Kasahara, Yuuya and Obika, Satoshi and Okamura, Yasushi and Kikuchi, Akira},
journal = {In Vitro Cellular \& Developmental Biology - Animal},
year = {2026},
doi = {10.1007/s11626-026-01154-2},
url = {https://doi.org/10.1007/s11626-026-01154-2}
}